InvestDashboard.com



Cleveland BioLabs, Inc. (CBLI)



$1.22
52 Week Low
$3.53
2017-04-28 14:47:07 MDT
$4.47
52 Week High

Basic Info

Healthcare
Sector
Biotechnology
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $43,290,000Micro Cap (Less than $200M)
Analyst Recommendation:3Analysts say: Neutral. (1=Strong Buy, 5=Strong Sell)
Beta: -1.37 Unusual negative beta. Good for diversity? Stock may go up when market goes down, and down when market goes up.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: Unknown
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: 77.39%
% Above 200 DayMA: 105.23%
CBLI Performance 52 Weeks: 73.16%
S&P 500 Performance 52 Weeks: 12.50%
Uptrend is still intact: CBLI is above both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low.
CBLI outperforming S&P 500 by 60.66% the last 52 Weeks.

Profile


More Valuation

Price To Book: 5.84
OK Value. Low Price to Book means better value. A P/B value of 5 or less is great.
EV to EBITDA: -4.56
Unknown EV to EBITDA ratio

More Info

Field Value Average Comments
% Held By Insiders3.83% 17.28%Held by fewer than average Insiders.
% Held By Institutions3.00% 62.07%Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price?
Short % Of Float0.34% 07.02% Shorted percentage less than average percent. Is stock loved? Do traders and investors believe in the stock?
Debt to EquityN/A 1.08Unknown.
Profit Margin %-75.57%-00.18% Profit Margin is less than average.
Operating Margin %-180.65%-05.28% Operating Margin less than average percent. Stock can do better than this?
Return on Equity %-18.58%-08.79% Return on Equity less than average percent. Stock can do better than this?
Return on Assets %-21.57%-01.29% Return on Assets less than average percent. Stock can do better than this?
Revenue Per Employee $234,666.67 $883,096.70 Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard.
Price to Cash 2.54 5.52 Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Stock is Above Short Term 50DMA: 77.39%

  2. Stock is Above Long Term 200DMA: 105.23%

  3. Stock outperforming S&P 500 over last 52 weeks: 60.66%

  4. Price to Cash Ratio (2.54) is less than average. Good. Company has more cash as percentage of price than other companies.

  5. Shorted less than average: 0.34%

CONS:
  1. Profit Margin is negative: -75.57%

  2. Operating Margin is negative: -180.65%

  3. Return on Equity is negative: -18.58%

  4. Return on Assets is negative: -21.57%

  5. Beta is negative. It might be good for diversity, but could also be a warning flag: -1.37


Headlines


Stock Chart


InvestDashboard.com CBLI: Cleveland BioLabs, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.